» Articles » PMID: 24867077

Restraint Stress Attenuates Nicotine's Locomotor Stimulant but Not Discriminative Stimulus Effects in Rats

Overview
Publisher Elsevier
Date 2014 May 29
PMID 24867077
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Stress enhances the locomotor stimulant and discriminative stimulus effects of several addictive drugs (e.g., morphine) in rodents, yet interactions between stress and nicotine's effects in these behavioral models have not been well established. To this end, the current studies examined the effects of restraint stress on nicotine-induced locomotor activity and nicotine discrimination in rats. We used a novel approach in which onset of stress and nicotine administration occurred concurrently (i.e., simultaneous exposure) to simulate effects of stress on ongoing tobacco use, as well as a more traditional approach in which a delay was imposed between stress and nicotine administration (i.e., sequential exposure). Simultaneous exposure to stress reduced the rate of locomotor sensitization induced by daily injections of nicotine (0.4 mg/kg, s.c.). A lower dose of nicotine (0.1mg/kg, s.c.) produced modest effects on activity that were generally unaffected by simultaneous exposure to stress. Sequential exposure to stress and nicotine (0.4 mg/kg, s.c.) slightly suppressed nicotine-induced activity but did not influence rate of locomotor sensitization. Neither simultaneous nor sequential exposure to stress influenced the discriminative stimulus effects of nicotine (0.01-0.2mg/kg, s.c.). These data show that restraint stress reduces nicotine's locomotor stimulant effects, particularly when onset of stress and nicotine exposure occurs simultaneously, but does not influence nicotine discrimination. These findings contrast with the ability of stress to enhance the effects of other drugs in these models. This study also suggests that studying the influence of simultaneous stress exposure on drug effects may be useful for understanding the role of stress in addiction.

Citing Articles

The role of β-Nicotyrine in E-Cigarette abuse liability I: Drug Discrimination.

Smethells J, S W, P M, Mg L, Ap H bioRxiv. 2024; .

PMID: 39071347 PMC: 11275838. DOI: 10.1101/2024.07.12.603310.


The Intergenerational Transmission of Developmental Nicotine Exposure-Induced Neurodevelopmental Disorder-Like Phenotypes is Modulated by the Chrna5 D397N Polymorphism in Adolescent Mice.

Buck J, ONeill H, Stitzel J Behav Genet. 2021; 51(6):665-684.

PMID: 34159514 PMC: 8925929. DOI: 10.1007/s10519-021-10071-x.


Consequence of Two Protocols of Social Defeat Stress on Nicotine-Induced Psychomotor Effects in Mice.

Domingues L, Antonio B, de Oliveira M, de Quadros I Biomed Res Int. 2019; 2019:5404251.

PMID: 31179329 PMC: 6507117. DOI: 10.1155/2019/5404251.


Effects of the adenosinergic system on the expression and acquisition of sensitization to conditioned place preference in morphine-conditioned rats.

Listos J, Talarek S, Listos P, Orzelska J, Lupina M, Fidecka S Naunyn Schmiedebergs Arch Pharmacol. 2015; 389(2):233-41.

PMID: 26638209 PMC: 4715847. DOI: 10.1007/s00210-015-1190-6.


Nicotine-Cadmium Interaction Alters Exploratory Motor Function and Increased Anxiety in Adult Male Mice.

Chris Ajonijebu D, Adeniyi P, Adekeye A, Olatunji B, Ishola A, Ogundele O J Neurodegener Dis. 2015; 2014:359436.

PMID: 26317007 PMC: 4437340. DOI: 10.1155/2014/359436.

References
1.
Badiani A, Anagnostaras S, Robinson T . The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment. Psychopharmacology (Berl). 1995; 117(4):443-52. DOI: 10.1007/BF02246217. View

2.
Forget B, Wertheim C, Mascia P, Pushparaj A, Goldberg S, Le Foll B . Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction. Neuropsychopharmacology. 2010; 35(8):1751-60. PMC: 3055474. DOI: 10.1038/npp.2010.42. View

3.
Enrico P, Sirca D, Mereu M, Peana A, Mercante B, Diana M . Acute restraint stress prevents nicotine-induced mesolimbic dopaminergic activation via a corticosterone-mediated mechanism: a microdialysis study in the rat. Drug Alcohol Depend. 2012; 127(1-3):8-14. DOI: 10.1016/j.drugalcdep.2012.06.006. View

4.
Zislis G, Desai T, Prado M, Shah H, Bruijnzeel A . Effects of the CRF receptor antagonist D-Phe CRF(12-41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats. Neuropharmacology. 2007; 53(8):958-66. PMC: 2330281. DOI: 10.1016/j.neuropharm.2007.09.007. View

5.
Roiko S, Harris A, Keyler D, Lesage M, Zhang Y, Pentel P . Combined active and passive immunization enhances the efficacy of immunotherapy against nicotine in rats. J Pharmacol Exp Ther. 2008; 325(3):985-93. DOI: 10.1124/jpet.107.135111. View